SYNVISC (HYLAN G-F 20)
FDA premarket approval P940015/S005 · decided 2000-09-12
Approval details
- PMA number
- P940015
- Supplement
- S005
- Supplement type
- Real-Time Process
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- SYNVISC (HYLAN G-F 20)
- Generic name
- Acid, hyaluronic, intraarticular
- Applicant
- Sanofi Genzyme Corp.
- Date received
- 2000-03-31
- Decision date
- 2000-09-12
- Days to decision
- 165 days
- Decision code
- APPR
- Product code
- MOZ
- Advisory committee
- Orthopedic
- Expedited review
- No
- Location
- Cambridge, MA
- Statement
- APPROVAL FOR A LABELING CHANGE EXTENDING THE TIME OF TREATMENT EFFECT TO 26 WEEKS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.